Indicated for: myeloproliferative neoplasms; sickle cell disease
Substance: hydroxycarbamide (antineoplastic agent)
ATC: L01XX05 (Antineoplastic and immunomodulating agents | Other antineoplastic agents)
Hydroxyurea is a medication used to treat certain types of cancer, such as chronic myeloid leukemia, and other conditions like sickle cell anemia. It works by inhibiting DNA synthesis, which slows the growth of cancerous or abnormal cells.
The medication is taken orally, as directed by a doctor.
Side effects may include nausea, vomiting, decreased blood cell counts, fatigue, or skin rashes. In rare cases, severe allergic reactions or hematologic toxicity may occur.
Patients should be closely monitored during treatment and inform their doctor about any other medications they are taking. Pregnant or breastfeeding women should not use this medication.